Pulse Biosciences, Inc.

Healthcare

NASDAQ:PLSE · NASDAQ Capital Market

Market Cap $1.69B Beta 1.66 P/E (TTM) -22.2

$24.37 -9.37%

-$2.52 today

52W Low $12.56High $28.53

Vol 0.40M · Avg 0.31M

EPS (TTM)-$1.10

Medical - Instruments & Supplies

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+54.53%

Period High

$27.10

Period Low

$12.66

Latest

$24.37

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Dianthus Therapeutics, Inc.

NASDAQ:DNTH

$3.43B

NovoCure Limited

NASDAQ:NVCR

$2.06B

Atai Beckley Inc.

NASDAQ:ATAI

$1.44B

STAAR Surgical Company

NASDAQ:STAA

$1.41B

Immatics N.V.

NASDAQ:IMTX

$1.26B

Kestra Medical Technologies, Ltd.

NASDAQ:KMTS

$1.22B

Nektar Therapeutics

NASDAQ:NKTR

$1.16B

OPKO Health, Inc.

NASDAQ:OPK

$1.07B

Beta Bionics, Inc.

NASDAQ:BBNX

$647.48M

LifeMD, Inc.

NASDAQ:LFMD

$227.30M

What is the latest PLSE filing?

The latest filing shown is 8-K dated Jun 12, 2026.

How many recent filings does PLSE have?

Intrinsic Alpha currently shows 20 recent filings for PLSE.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.